The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular analysis of advanced colorectal cancer in a patient cohort of Hispanics, African Americans, and Caucasians within a diverse single institution.
 
Nadia Ashai
No Relationships to Disclose
 
Mateo Mejia Saldarriaga
No Relationships to Disclose
 
Devika Rao
Stock and Other Ownership Interests - Baxter (I)
 
Matthew Stuart
No Relationships to Disclose
 
Wei Zhang
No Relationships to Disclose
 
Sanjay Goel
Research Funding - Oncolytics (Inst)
Patents, Royalties, Other Intellectual Property - I have a patent with a co-inventor, John Mariadason, Ph.D, entitled "Method Of Determining The Sensitivity Of Cancer Cells To EGFR Inhibitors Including Cetuximab, Panitumumab And Erlotinib.", Patent No. 20090258364
 
Balazs Halmos
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Foundation Medicine; Genentech/Roche; Guardant Health; Lilly; Merck; Novartis; Pfizer; Spectrum Pharmaceuticals; Takeda
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Guardant Health (Inst); Merck (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); Takeda (Inst)
 
Lakshmi Rajdev
Patents, Royalties, Other Intellectual Property - Bristol Myers Squibb, Boston Biomedical (Inst)